DJ AbbVie Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. $(ABBV)$ shed 2.32% to $216.75 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.26% to 6,944.47 and the Dow Jones Industrial Average rising 0.60% to 49,442.44.
The stock's fall snapped a two-day winning streak.
AbbVie Inc. closed 11.46% below its 52-week high of $244.81, which the company reached on October 1st.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 0.47% to $219.57, Pfizer Inc. $(PFE)$ rose 1.21% to $25.89, and Amgen Inc. $(AMGN)$ rose 0.32% to $330.03.
Trading volume (6.1 M) eclipsed its 50-day average volume of 6.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled January 15, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
January 15, 2026 16:31 ET (21:31 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments